<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01365143</url>
  </required_header>
  <id_info>
    <org_study_id>11-002288</org_study_id>
    <nct_id>NCT01365143</nct_id>
  </id_info>
  <brief_title>Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <brief_summary>
    <textblock>
      To date, no study has prospectively compared open versus robotic radical prostatectomy in a
      randomized fashion for patients with prostate cancer. For patients with newly diagnosed
      prostate cancer who choose surgical management, the choice of surgical approach is often
      limited to surgeon preference and experience. This study will prospectively randomize
      patients with localized prostate cancer who are candidates for surgical management to open
      versus robotic radical prostatectomy.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Closing due to slow enrollment
  </why_stopped>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Trifecta</measure>
    <time_frame>at 2 years</time_frame>
    <description>Free from biochemical recurrence, continent, and potent 2 years after radical prostatectomy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Continence</measure>
    <time_frame>at 3, 12, and 24 months</time_frame>
    <description>Continent of urine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Potency</measure>
    <time_frame>at 3, 12, and 24 months</time_frame>
    <description>Satisfactory erections</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free from biochemical recurrence</measure>
    <time_frame>at 3, 12, and 24 months</time_frame>
    <description>PSA &lt;0.2 ng/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute complications</measure>
    <time_frame>Within 30 days of surgery</time_frame>
    <description>Any complication according to Calvien classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term complication</measure>
    <time_frame>&gt;30 days</time_frame>
    <description>bladder neck contracture, lymphocele</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated blood loss</measure>
    <time_frame>Participants will be followed for the duration of the operation, an expected average of 3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>Participants will be followed for the duration of the operation, an expected average of 3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Participants will be followed for the duration of the hospital stay, an expected average of 1-2 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Prostatic Neoplasms</condition>
  <condition>Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>Open Radical Prostatectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Robotic radical prostatectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robotic Radical Prostatectomy</intervention_name>
    <description>Robotic assisted radical prostatectomy</description>
    <arm_group_label>Robotic radical prostatectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Radical Prostatectomy</intervention_name>
    <description>Open radical prostatectomy</description>
    <arm_group_label>Open Radical Prostatectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Biopsy proven adenocarcinoma of the prostate

          -  Deemed a surgical candidate for a bilateral nerve bundle preservation

          -  Potent

          -  Continent of urine

          -  Surgical candidate for both open and robotic nerve-sparing radical prostatectomy

          -  Age &gt;18

        Exclusion Criteria:

          -  Previous treatment of prostate cancer (radiation, hormones, etc.)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2011</study_first_submitted>
  <study_first_submitted_qc>June 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2011</study_first_posted>
  <last_update_submitted>May 30, 2014</last_update_submitted>
  <last_update_submitted_qc>May 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2014</last_update_posted>
  <responsible_party>
    <name_title>R. Houston Thompson, MD</name_title>
    <organization>Mayo Clinic</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

